Responses
Clinical science
Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy
Compose a Response to This Article
Other responses
No responses have been published for this article.